Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...

Compared to Sotyktu (deucravacitinib), which was approved by the FDA for plaque psoriasis in 2022 and brought in sales of more than $200 million in the first nine months of this year, zasocitinib is ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

The clinical-stage biotechnology company is seeking regulatory clearance to begin clinical trials of CYPS317, an allogeneic ...

MOBILE, Ala. (WALA) -There is now a new treatment option for the estimated 2 million people in the United States living with moderate-to-severe plaque psoriasis whose symptoms may make day-to-day life ...

Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, announced new Phase 3b topline Week 16 results from Cohort A of the VISIBLE trial, the first prospective, large-scale, randomized-controlled ...

Please provide your email address to receive an email when new articles are posted on . With narrowband ultraviolet B (UVB) therapy, about 70% of patients with psoriasis can achieve a 75% reduction in ...

Decreased coronary flow was associated with severe psoriasis, according to one study. The largest study to date on the relationship between severe psoriasis and coronary microvascular dysfunction (CMD ...

Posters presented at the American Academy of Dermatology Annual Meeting demonstrated both short- and long-term efficacy and safety profiles of brodalumab in patients with moderate to severe psoriasis.

Claire Spurgin, 25, was first diagnosed with psoriasis six years ago, and scaly red rashes have covered her entire body ever since. She is stripping down on social media to raise awareness about the ...

Psoriasis is a chronic skin disease where red, scaly, itchy patches break out all over your body. It’s an autoimmune disease in which your immune system goes haywire and triggers inflammation of your ...